AFFIMED N.V.       EO-,10
AFFIMED N.V. EO-,10
Action · NL0015001ZQ0 · AFMD · A407ZR (XNCM)
Aperçu Indicateurs financiers
0,15 EUR
-13,88 % -0,02 EUR
Frankfurt (XNAS) · Cours et graphiques actuels sur MoneyPeak
19.05.2025 23:59

Cours actuels de AFFIMED N.V. EO-,10

BourseTickerDeviseDernier échangeCoursVariation journalière
XNAS: NASDAQ
NASDAQ
AFMD
USD
19.05.2025 23:59
0,17 USD
0,29 USD
-40,96 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
2,33 % 1,53 % -77,95 % -82,97 % -92,99 % -97,36 % -99,50 %

Profil de l'entreprise pour AFFIMED N.V. EO-,10 Action

Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispecific epidermal growth factor receptor, and CD16A-binding innate cell engager, which is in Phase IIa clinical trial for the treatment of advanced cancers; AFM28, an innate cell engager (ICE), which is in preclinical development to treat acute myeloid leukemia; and AFM32, an ICE candidate that is in preclinical development for the treatment of solid tumors. Affimed N.V. has collaboration agreements with The University of Texas MD Anderson Cancer Center; Genentech, Inc.; and Roivant Sciences Ltd., as well as research funding agreement with The Leukemia & Lymphoma Society. The company was formerly known as Affimed Therapeutics B.V. and changed its name to Affimed N.V. in October 2014. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany.

Données de l'entreprise

Nom AFFIMED N.V. EO-,10
Société Affimed N.V.
Symbole AFMD
Site web https://www.affimed.com
Marché d'origine XNCM Frankfurt
WKN A407ZR
ISIN NL0015001ZQ0
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Dr. Shawn M. Leland Pharm.D., R.Ph.
Capitalisation boursière 11 Mio
Pays Allemagne
Devise EUR
Employés 0,1 T
Adresse Technologiepark, 69120 Heidelberg
Date d'introduction en bourse 2014-09-12

Symboles boursiers

Nom Symbole
Frankfurt A28A.F
NASDAQ AFMD

Autres actions

Les investisseurs qui détiennent AFFIMED N.V. EO-,10 ont également les actions suivantes dans leur portefeuille :
ASHFORD HOSPIT.TRUST NEW
ASHFORD HOSPIT.TRUST NEW Action
DOW CHEM. 14/44
DOW CHEM. 14/44 Obligation
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025